Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXE
326
DELISTED
Anixter International Inc
AXE
| $753K | 0.03% |
7,522
+2,499
| +50% | +$246K |
|
327
Barings BDC
BBDC
$978M
| $752K | 0.03% |
26,500
+6,760
| +34% | +$177K |
|
328
Verisk Analytics
VRSK
$24.4B
| $752K | 0.03% |
12,528
+1,671
| +15% | +$99.9K |
|
|
SPLS
329
DELISTED
Staples Inc
SPLS
| $752K | 0.03% |
69,400
+4,300
| +7% | +$51K |
|
330
General Dynamics
GD
$104B
| $751K | 0.03% |
6,442
-26,168
| -80% | -$2.98M |
|
331
Amkor Technology
AMKR
$12.5B
| $750K | 0.03% |
67,058
+10,191
| +18% | +$94K |
|
|
LLL
332
DELISTED
L3 Technologies, Inc.
LLL
| $749K | 0.03% |
6,200
-900
| -13% | -$107K |
|
333
Merit Medical Systems
MMSI
$5.42B
| $744K | 0.03% |
49,267
+10,768
| +28% | +$149K |
|
334
ICF International
ICFI
$1.6B
| $742K | 0.03% |
20,982
+3,216
| +18% | +$121K |
|
335
Fidelity National Information Services
FIS
$21.3B
| $740K | 0.03% |
13,520
+9,220
| +214% | +$495K |
|
336
Arista Networks
ANET
$238B
| $738K | 0.03% |
+189,200
| New | +$761K |
|
337
Everest Group
EG
$14.2B
| $738K | 0.03% |
4,600
-2,800
| -38% | -$443K |
|
|
AET
338
DELISTED
Aetna Inc
AET
| $738K | 0.03% |
9,100
+2,487
| +38% | +$188K |
|
339
Cigna
CI
$73.3B
| $736K | 0.03% |
8,000
-12,109
| -60% | -$1.04M |
|
340
Commercial Metals
CMC
$7.34B
| $736K | 0.03% |
42,534
+8,762
| +26% | +$163K |
|
|
CXP
341
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $733K | 0.03% |
28,171
+17,174
| +156% | +$468K |
|
342
JetBlue
JBLU
$1.85B
| $728K | 0.03% |
67,100
-58,040
| -46% | -$537K |
|
|
ECHO
343
DELISTED
Echo Global Logistics, Inc.
ECHO
| $728K | 0.03% |
37,955
+11,923
| +46% | +$219K |
|
344
TD Synnex
SNX
$20B
| $726K | 0.03% |
19,922
-11,548
| -37% | -$388K |
|
345
United Therapeutics
UTHR
$22B
| $723K | 0.03% |
8,168
-999
| -11% | -$96.1K |
|
346
Labcorp
LH
$27.3B
| $719K | 0.03% |
+8,171
| New | +$708K |
|
347
Southwest Gas
SWX
$6.44B
| $718K | 0.03% |
13,595
+1,595
| +13% | +$84.6K |
|
348
Jefferies Financial Group
JEF
$12.1B
| $717K | 0.03% |
30,569
-5,579
| -15% | -$130K |
|
349
Tractor Supply
TSCO
$18.2B
| $716K | 0.03% |
+59,310
| New | +$777K |
|
350
APA Corp
APA
$15.2B
| $714K | 0.03% |
7,100
-5,121
| -42% | -$464K |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.